Pfizer: all 4,072 studies
Page 7 of 41. Open to participants first (153), then studies with results posted, then the rest; newest registration first within each.
- Patient Perception of Treatment Burden in Weekly Versus Daily Growth Hormone Injections in Children With GHDCompletedNCT03831880Phase 3Results posted
- Trial to Evaluate the Safety and Immunogenicity of 3 Lots of 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naïve AdultsCompletedNCT03828617Phase 3Results posted
- Observational, Real World Study Of Inflectra In Patients With Inflammatory Bowel DiseaseCompletedNCT03801928Results posted
- JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic DermatitisCompletedNCT03796676Phase 3Results posted
- Study of PF 04965842 Effect on MATE1/2K Activity in Healthy ParticipantsCompletedNCT03796182Phase 1Results posted
- Observational Study Investigating Clinical & Anthropometric Characteristics of Children With Achondroplasia.TerminatedNCT03794609Results posted
- A Bioequivalence Study of Testosterone Cypionate in Hypogonadal MalesCompletedNCT03792477Phase 1Results posted
- Study To Describe The Safety Of 13-valent Pneumococcal Conjugate Vaccine In Children 6 To 17 Years Of Age In IndiaCompletedNCT03777865Phase 4Results posted
- A Study To Assess Pharmacodynamics, Safety And Tolerability Of PF-05221304 And PF-06865571 Co-Administered For 6 Weeks In Adults With Non-Alcoholic Fatty Liver Disease.CompletedNCT03776175Phase 2Results posted
- Immunogenicity and Safety Study of a Vaccine Against Lyme Borreliosis, in Healthy Adults Aged 18 to 65 Years. Randomized, Controlled, Observer-blind Phase 2 Study.CompletedNCT03769194Phase 2Results posted
- Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Multivalent Group B Streptococcus Vaccine In Healthy Nonpregnant Women And Pregnant Women And Their InfantsCompletedNCT03765073Phase 2Results posted
- Trial to Evaluate the Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-naïve AdultsCompletedNCT03760146Phase 3Results posted
- A Natural History Study In Chinese Male Patients With Duchenne Muscular DystrophyCompletedNCT03760029Not applicableResults posted
- PF-06651600 for the Treatment of Alopecia AreataCompletedNCT03732807Phase 2/3Results posted
- Efficacy and Safety Trial of Rimegepant for Migraine Prevention in AdultsCompletedNCT03732638Phase 2/3Results posted
- Evaluating QTc, PK, Safety of Gemtuzumab Ozogamicin (GO) in Patients With CD33+ R/R AMLCompletedNCT03727750Phase 4Results posted
- Hepatic Impairment Study for Lorlatinib in Cancer PatientsTerminatedNCT03726333Phase 1Results posted
- Actual Use and Compliance Study Of Ibuprofen 600 Mg Immediate Release/Extended Release Tablets In At-Risk OTC ConsumersTerminatedNCT03722238Phase 3Results posted
- Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical TherapyCompletedNCT03720470Phase 3Results posted
- Descriptive Observational Study ALK-2016-CPHGCompletedNCT03718117Results posted
- A Phase 2b Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Active Non-segmental Vitiligo SubjectsCompletedNCT03715829Phase 2Results posted
- Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid TumorsCompletedNCT03709680Phase 2Results posted
- Rheumatoid Arthritis Satisfaction Outcome ResearchCompletedNCT03703817Results posted
- PF-06952229 Treatment in Adult Patients With Advanced Solid TumorsTerminatedNCT03685591Phase 1Results posted
- A Study Of Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible PatientsCompletedNCT03677596Phase 4Results posted
- Vaccine-Based Immunotherapy Regimen For NSCLC and TNBCTerminatedNCT03674827Phase 1Results posted
- Long Term Safety Observation of Crizotinib in Chinese NSCLC PopulationTerminatedNCT03672643Phase 4Results posted
- A Renal Impairment Study for PF-04965842CompletedNCT03660241Phase 1Results posted
- A Study of Weekly Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With Safety Run-in (innovaTV 208)CompletedNCT03657043Phase 2Results posted
- A Safety Study For Prevenar 13 Among Chinese ChildrenCompletedNCT03656939Results posted
- Clinical Trial of Brentuximab Vedotin in Classical Hodgkin LymphomaTerminatedNCT03646123Phase 2Results posted
- Xeljanz Special Investigation for Long-term Use in UC PatientsCompletedNCT03643211Results posted
- Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100)TerminatedNCT03642132Phase 3Results posted
- A Study of Avelumab, Binimetinib and Talazoparib in Patients With Locally Advanced or Metastatic RAS-mutant Solid TumorsTerminatedNCT03637491Phase 1/2Results posted
- Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring SubjectsCompletedNCT03627767Phase 3Results posted
- A Hepatic Impairment Study for PF-04965842.CompletedNCT03626415Phase 1Results posted
- A Study to Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%)CompletedNCT03587116Phase 3Results posted
- A Safety Study of SEA-BCMA in Patients With Multiple MyelomaTerminatedNCT03582033Phase 1Results posted
- Efficacy, Safety, and Tolerability of ATM-AVI in the Treatment of Serious Infection Due to MBL-producing Gram-negative BacteriaTerminatedNCT03580044Phase 3Results posted
- Evaluation Of Clostridium Difficile Vaccine Lot Consistency In Healthy Adults 65 To 85 Years Of AgeCompletedNCT03579459Phase 3Results posted
- Study Evaluating Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic DermatitisCompletedNCT03575871Phase 3Results posted
- A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese Infants and Young ChildrenCompletedNCT03574389Phase 3Results posted
- Study to Assess the Effect of Long-term Treatment With Voxelotor in Participants Who Have Completed Treatment in Study GBT440-031TerminatedNCT03573882Phase 3Results posted
- Non-interventional, Retrospective Cohort Study to Explore OAC Treatment in KoreaCompletedNCT03572972Results posted
- A Study to Evaluate the Safety and Immunogenicity of an Adjuvanted RSV Vaccine in Healthy Older AdultsTerminatedNCT03572062Phase 2Results posted
- A Safety And Immunogenicity Study Of A 13-valent Pneumococcal Conjugate Vaccine In Japanese Subjects Aged 6 To 64 Years.CompletedNCT03571607Phase 3Results posted
- Safety and Effectiveness of Oral Anticoagulants in Patients With Non-valvular Atrial FibrillationCompletedNCT03570047Results posted
- Javelin BRCA/ATM: Avelumab Plus Talazoparib in Patients With BRCA or ATM Mutant Solid TumorsTerminatedNCT03565991Phase 2Results posted
- Study to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine Given With Prevnar 13 in Healthy InfantsTerminatedNCT03550313Phase 2Results posted
- Study To Describe The Safety, Tolerability, And Immunogenicity Of 13- Valent Pneumococcal Conjugate Vaccine Formulated In Multidose Vials When Given With Routine Pediatric Vaccines In Healthy Infants In IndiaCompletedNCT03548337Phase 4Results posted
- Lorlatinib Renal Impairment StudyCompletedNCT03542305Phase 1Results posted
- A Study of Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI in Subjects Aged ≥ 2 Years, With Mild-moderate ADTerminatedNCT03539601Phase 4Results posted
- 4-Week, Multiple-dose, Dose-escalating Study In Patients With Type 2 DiabetesCompletedNCT03538743Phase 1Results posted
- "Retrospective Study to Identify Clinical Factors Related to a High Benefit of Axitinib in mRCC"CompletedNCT03538717Results posted
- A Study to Describe the Safety and Immunogenicity of a RSV Vaccine in Healthy AdultsCompletedNCT03529773Phase 2Results posted
- A Study of PF-06873600 in People With CancerTerminatedNCT03519178Phase 1/2Results posted
- 2-Week Study In People With Nonalcoholic Fatty Liver DiseaseCompletedNCT03513588Phase 1Results posted
- Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine in Healthy InfantsCompletedNCT03512288Phase 2Results posted
- Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS)CompletedNCT03502616Phase 3Results posted
- Talazoparib For Neoadjuvant Treatment Of Germline BRCA1/2 Mutation Patients With Early Human Epidermal Growth Factor Receptor 2 Negative Breast CancerTerminatedNCT03499353Phase 2Results posted
- Anaemetro I.V. Infusion 500mg Drug Use InvestigationCompletedNCT03491228Results posted
- Efficacy And Safety Of Tofacitinib In Chinese Subjects With Active Psoriatic ArthritisCompletedNCT03486457Phase 3Results posted
- A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF)TerminatedNCT03472560Phase 2Results posted
- Safety, Tolerability And Efficacy Study Of Topical PF-06763809 In Subjects With Mild To Moderate Chronic Plaque PsoriasisCompletedNCT03469336Phase 1Results posted
- Trial in Adult Subjects With Acute MigrainesCompletedNCT03461757Phase 3Results posted
- A Study to Evaluate PF-06730512 in Adults With Focal Segmental Glomerulosclerosis (FSGS)TerminatedNCT03448692Phase 2Results posted
- Apixaban Drug Utilization Study In Stroke Prevention In Atrial Fibrillation (Spaf)CompletedNCT03441633Results posted
- A Study of ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene MutationTerminatedNCT03439514Phase 3Results posted
- A Trial of Tisotumab Vedotin in Cervical CancerCompletedNCT03438396Phase 2Results posted
- A Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid LeukemiaCompletedNCT03416179Phase 3Results posted
- An Evaluation of the Safety and Pharmacokinetics of Tavaborole Topical Solution for the Treatment of Fungal Disease of the Toenail in Children and AdolescentsCompletedNCT03405818Phase 4Results posted
- Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPCActive, not recruitingNCT03395197Phase 3Results posted
- Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF-06700841 In Subjects With Moderate To Severe Crohn's DiseaseCompletedNCT03395184Phase 2Results posted
- Observational Study to Determine How Physicians Make Treatment Decisions in Patients Treated With Tofacitinib for Moderate to Severe Active Rheumatoid ArthritisCompletedNCT03387423Results posted
- PF-06741086 Long-term Treatment in Severe HemophiliaCompletedNCT03363321Phase 2Results posted
- A Study to Evaluate the Safety and Tolerability of PF-06939926 Gene Therapy in Duchenne Muscular DystrophyTerminatedNCT03362502Phase 1Results posted
- A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic DermatitisCompletedNCT03356977Phase 4Results posted
- Study to Evaluate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic DermatitisCompletedNCT03349060Phase 3Results posted
- A Phase 1 Study Of Talazoparib, PARP Inhibitor, In Japanese Patients With Advanced Solid TumorsCompletedNCT03343054Phase 1Results posted
- Safety and Tolerability Study Of PF-06835375 In Subjects With Seropositive Systemic Lupus Erythematosus Or Rheumatoid ArthritisCompletedNCT03334851Phase 1Results posted
- Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid TumorsTerminatedNCT03330405Phase 1/2Results posted
- A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria.CompletedNCT03329092Phase 3Results posted
- Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced MalignanciesTerminatedNCT03317496Phase 1/2Results posted
- A Trial To Evaluate A Multivalent Pneumococcal Conjugate Vaccine In Healthy Adults 50-85 Years Of AgeCompletedNCT03313050Phase 2Results posted
- Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Adults 60 Through 64 Years of AgeCompletedNCT03313037Phase 2Results posted
- Safety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-Advanced or Metastatic Triple-Negative Breast CancerCompletedNCT03310957Phase 1/2Results posted
- Study of PF-05221304 in Subjects With Varying Degrees of Hepatic ImpairmentCompletedNCT03309202Phase 1Results posted
- A Study Of Avelumab In Combination With Axitinib In Advanced HCC (VEGF Liver 100)CompletedNCT03289533Phase 1Results posted
- PF-06804103 Dose Escalation in HER2 Positive and Negative (Negative Only in Part 2) Solid TumorsTerminatedNCT03284723Phase 1Results posted
- A Study of Tofacitinib in Patients With Ulcerative Colitis in Stable RemissionTerminatedNCT03281304Phase 4Results posted
- Palbociclib in Real World PracticeCompletedNCT03280303Results posted
- Immunization To Prevent Acute COPD ExacerbationsTerminatedNCT03276754Results posted
- A First in HumanTrial to Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-06755347TerminatedNCT03275740Phase 1Results posted
- Study of Binimetinib + Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Microsatellite-stable (MSS) Metastatic Colorectal Cancer With RAS MutationCompletedNCT03271047Phase 2Results posted
- Efficacy, Safety and Tolerability of PF-06687234 as Add-on Therapy to Infliximab in Active UC Subjects Not in Remission.TerminatedNCT03269695Phase 2Results posted
- PF-06863135 As Single Agent And In Combination With Immunomodulatory Agents In Relapse/Refractory Multiple MyelomaCompletedNCT03269136Phase 1Results posted
- Open Label Safety Study in Acute Treatment of MigraineCompletedNCT03266588Phase 2/3Results posted
- A Study of Crisaborole Ointment 2% in Adult Japanese Healthy Subjects and Adult Japanese Subjects With Mild To Moderate Atopic DermatitisCompletedNCT03260595Phase 1Results posted
- 6-week Safety and PD Study in Adults With NAFLDCompletedNCT03256526Phase 2Results posted
- Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD)CompletedNCT03248882Phase 2Results posted